Skip to main content
Clinical Trials/EUCTR2014-005363-33-ES
EUCTR2014-005363-33-ES
Active, not recruiting
Not Applicable

Reducing Micro Vascular dysfunction In revascularized STEMI patients by off-target properties of ticagrelor - REDUCE-MVI

VU university medical center0 sites110 target enrollmentFebruary 24, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ST elevation myocardial infarction (STEMI)
Sponsor
VU university medical center
Enrollment
110
Status
Active, not recruiting
Last Updated
10 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2016
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
VU university medical center

Eligibility Criteria

Inclusion Criteria

  • 1\. Provision of informed consent
  • 2\. Patients presenting with STEMI \<12 hours
  • 3\. Successful PCI of the infarct\-related vessel with a modern DES
  • 4\. Intermediate stenosis in non\-infarct\-related vessel (50\-90%)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 70
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 40

Exclusion Criteria

  • 1\. history of myocardial infarction
  • 2\. Participation in another clinical study with an investigational product
  • during the preceding 30 days
  • 3\. history of cerebrovascular accident (CVA) or 'transient ischaemic
  • attack' (TIA)
  • 4\. History of intracranial haemorrhage
  • 5\. indication or use of oral anticoagulant therapy (i.e. acenocoumarol)
  • 6\. severe liver dysfunction (Child\-Pughscore 10?15\)
  • 7\. congestive heart failure
  • 8\. cardiogenic shock

Outcomes

Primary Outcomes

Not specified

Similar Trials